All In Biotech

Free tool

FAERS Monitor: Otrexup

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204824 or its brand name (Otrexup, Methotrexate). Reports on generic versions are filed under their own applications.

Reports

417,645

Serious

315,340

76% of reports

Hospitalization

119,785

Death reported

34,414

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective75,997
  • rheumatoid arthritis38,640
  • arthralgia36,856
  • pain36,004
  • off label use35,326
  • fatigue29,671
  • nausea24,467
  • joint swelling22,658
  • headache21,327
  • rash20,369
  • condition aggravated20,265
  • drug intolerance20,024
  • diarrhoea18,682
  • pain in extremity18,139
  • pyrexia17,490

Reports by year received

View as table
YearReports
20045,129
20055,083
20064,969
20077,782
20088,995
20099,160
20109,678
201110,610
201214,953
201316,975
201416,967
201520,365
201621,909
201722,749
201832,398
201932,440
202039,843
202126,547
202229,258
202326,872
202423,124
202520,104
202611,726

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,636,514 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal38,64025.525.2602,394
drug intoleranceSignal20,02412.912.7175,152
joint swellingSignal22,65811.411.2175,733
arthralgiaSignal36,8564.84.8103,112
condition aggravatedSignal20,2653.53.534,709
pain in extremitySignal18,1393.23.226,703
painSignal36,0043.13.048,829
drug ineffectiveSignal75,9973.03.0103,261
pyrexiaSignal17,4902.62.617,023
rashSignal20,3692.42.416,513
off label useSignal35,3262.12.119,701
fatigue29,6712.01.913,840
headache21,3271.71.76,656
nausea24,4671.61.65,166
diarrhoea18,6821.51.52,824

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.